We next tested whether we could successfully activate and repress PHOX2B expression and detected robust activation by targeting dCas9-VPR at its promoter in the neuroblastoma-derived cell line SHSY-5Y (Figure S1B). This evidence concerns the gene PHOX2B and neuroblastoma.